ADMA Biologics, Inc. (ADMA)
15.48
+0.33
(+2.18%)
USD |
NASDAQ |
Mar 16, 12:48
ADMA Biologics Market Cap : 3.687B for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 23.51M |
| AtriCure, Inc. | 1.510B |
| Ligand Pharmaceuticals, Inc. | 4.168B |
| ACADIA Pharmaceuticals, Inc. | 3.661B |
| Savara, Inc. | 1.064B |
Market Cap Related Metrics
| PE Ratio | 25.84 |
| PS Ratio | 7.448 |
| Price to Book Value | 7.724 |
| Price to Free Cash Flow | 138.14 |
| Price | 15.48 |
| Earnings Yield | 3.87% |
| Operating PE Ratio | 19.85 |
| Normalized PE Ratio | 25.44 |